Monitor for future Form 4 filings that would indicate actual open-market trades or option exercises by either insider, which would provide more signal. These Form 3s are purely administrative and do not change the investment thesis.
Price Chart
Executive Summary
Two insiders at Latigo Biotherapeutics — CFO/Chief Business Officer Neha Krishnamohan and director Timothy P. Walbert — filed initial beneficial ownership statements (Form 3) on August 6, 2026, disclosing stock option grants received as part of their compensation. Krishnamohan holds options to purchase 686,026 shares at strike prices of $5.53 and $5.98, while Walbert holds options for 329,819 shares at $2.19 and $5.53. These are routine Section 16 initial filings triggered by insider status; no open-market transactions or material changes to the company's operations are disclosed.
Key Facts
- Neha Krishnamohan (CFO & Chief Business Officer) filed Form 3 on August 6, 2026, disclosing 3 stock option grants totaling 686,026 shares.
- Timothy P. Walbert (Director) filed Form 3 on August 6, 2026, disclosing 3 stock option grants totaling 329,819 shares.
- Options held by Krishnamohan have strike prices $5.53 (two grants) and $5.98, with vesting schedules beginning April 2025 and February 2026.
- Options held by Walbert have strike prices $2.19, $5.53, and $5.53, with vesting beginning October 2024 and January 2025.
- Both filings are routine initial ownership statements (Section 16) required upon becoming officers/directors; no open-market purchases or sales are reported.
Financial Impact
No immediate financial impact; option grants are standard compensation with multi-year vesting.
Risk Factors
- Option grants may eventually lead to dilution upon exercise; however, the amounts relative to total shares outstanding are not disclosed in these filings.
- No indication of current or pending business catalysts — these are routine compliance filings.
Investment Themes
Documents Analyzed
This report is based on 12 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (LTGO) — Batch item 1 | 0001866171-26-000002 |
| Document: 0001866171-26-000002-index-headers.html | 0001866171-26-000002 |
| Document: 0001866171-26-000002-index.html | 0001349376-26-000006 |
| Document: 0001866171-26-000002.txt | 0001866171-26-000002 |
| 3 Filing (LTGO) — Batch item 5 | 0001866171-26-000002 |
| Document: 0001866171-26-000002-index-headers.html | 0001866171-26-000002 |
| Document: 0001866171-26-000002-index.html | 0001866171-26-000002 |
| Document: 0001866171-26-000002.txt | 0001866171-26-000002 |
| 3 Filing (LTGO) — Batch item 9 | 0001349376-26-000006 |
| Document: 0001349376-26-000006-index-headers.html | 0001866171-26-000002 |
| Document: 0001349376-26-000006-index.html | 0001866171-26-000002 |
| Document: 0001349376-26-000006.txt | 0001866171-26-000002 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $23.04 $23.73 | ▲ +2.99% | ▲ +3.54% | $15.21 (−33.98%) |
Aug 12, 2026 10w ago | 3 | $19.38 $20.06 | ▲ +3.54% | ▲ +2.84% | $15.21 (−21.50%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 10, 2026 11w ago | 8-K | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.21 (−17.87%) |
Aug 7, 2026 11w ago | EFFECT | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.21 (−16.66%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.21 (−16.66%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.21 (−16.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers